Form 4 for SNTI Senti Biosciences Holdings, Inc.
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0001854270-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | SNTI | Rajangam Kanya | Pres, Chief Med, Dev. Off | S - Sale | $4.11 | -1,479 | 8,621 | -15% | -$6,074 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 1,297 | $4.07 | 8,803 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-06 | S | D | 182 | $4.37 | 8,621 | D | — | — |